Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1

Conditions

Lymphoma, Non-Hodgkin 10Lymphoma, Large B-Cell, Diffuse 5Lymphoma, B-Cell 5Lymphoma 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Leukemia, Lymphocytic, Chronic, B-Cell 4Lymphoma, Follicular 3Burkitt Lymphoma 3Myelodysplastic Syndromes 2Lymphoma, Mantle-Cell 2Sarcoma, Kaposi 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Multi-centric Castleman's Disease 1Leukemia, Myeloid, Acute 1Leukemia 1Hodgkin Disease 1Castleman Disease 1Acquired Immunodeficiency Syndrome 1

Interventions

Doxorubicin 6Cyclophosphamide 6Vincristine 5Dexamethasone 5Zidovudine 4Methotrexate 4Leucovorin 4Cytarabine 4Bleomycin 4Filgrastim 3sargramostim 2Etoposide 2Allopurinol 2tocilizumab 1fludarabine phosphate 1fludarabine 1Vinblastine 1Valganciclovir 1Thiotepa 1Tacrolimus 1Rituximab 1Prednisone 1Mitoxantrone 1Mitoguazone 1Methylprednisolone Hemisuccinate 1Methylprednisolone 1Melphalan 1Interviews as Topic 1HIV Testing 1Genes 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Acquired Immunodeficiency Syndrome × tocilizumab × Lymphoid × Clear all
NCT01441063 2020-10-27

Tocilizumab for KSHV-Associated Multicentric Castleman Disease

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
8 enrolled 18 charts
LymphoidSarcoma

Multi-centric Castleman's Disease, Acquired Immunodeficiency Syndrome, Castleman Disease, Sarcoma, Kaposi

Data powered by HemOnc (CC BY 4.0) Colophon âš¡